AVA-021

N/A

Report date: 2024/04/02 14:24:49

Base Information

Drug NameAVA-021
Drug Alias NamePD-L1 Affimer / LAG-3 Affimer (Avacta Life Sciences)AVA-021AVA021
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionLymphocyte activation gene 3 protein inhibitorsProgrammed death-ligand 1 blockers
TargetsProgrammed death-ligand 1Lymphocyte activation gene 3 protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvacta Life Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAvacta Life Sciences Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A